Hamidi Alamdari, DaryoushHafizi Lotfabadi, SaiedMavaji Darban, BehzadAgheli-Rad, MarziehSaadatian, ShahinHashemi, Seyed HadiBarazandeh Ahmadabadi, FatemehMorovatdar, NegarArastoo, MohammadBhushan, Bharat2021-07-162021-07-162021Hamidi Alamdari, D, Hafizi Lotfabadi, S, Mavaji Darban, B, Agheli-Rad, M, Saadatian, S, Hashemi, S H, Barazandeh Ahmadabadi, F, Morovatdar, N, Arastoo, M & Bhushan, B 2021, 'Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3', Aristotle Biomedical Journal, vol. 3, no. 2, pp. 12-18. < https://ejournals.lib.auth.gr/ABJ/article/view/8158/7922 >2653-9748ORCID: /0000-0002-0805-4949/work/97287775https://hdl.handle.net/2164/16825Funding: This work was supported by a grant from Mashhad University of Medical Sciences (Grant number: 990096, 990845). Acknowledgements: The authors gratefully acknowledge the nurses in Iamm Reza Hospital, Shariati Hospital, Hasheminejad Hospital for their excellent cooperation.7493987engCOVID-19TreatmentMethylene BlueMortalityR MedicineRJournal articlehttps://ejournals.lib.auth.gr/ABJ/article/view/8158/792232